Royal Papworth Hospital is a specialist heart and lung hospital, located on the Cambridge Biomedical Campus in Cambridgeshire, England. The Hospital is run by Royal Papworth Hospital NHS Foundation Trust.

There are 300 beds in Papworth Hospital.

During the past decade, Papworth Hospital conducted 103 clinical trials. In the 10-year time frame, 103 clinical trials started and 33 clinical trials were completed, i.e. on average, 32% percent of trials that started reached the finish line to date. In the past 5 years, 46 clinical trials started and 27 clinical trials were completed. i.e. 58.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Papworth Hospital" #1 sponsor was "Papworth Hospital NHS Foundation Trust" with 32 trials, followed by "Vertex Pharmaceuticals Incorporated" with 11 trials sponsored, "Actelion" with 8 trials sponsored, "Boston Scientific Corporation" with 7 trials sponsored and "Abbott Medical Devices" with 7 trials sponsored. Other sponsors include 86 different institutions and companies that sponsored additional 74 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Papworth Hospital" #1 collaborator was "Papworth Hospital NHS Foundation Trust" with 6 trials as a collaborator, "British Heart Foundation" with 4 trials as a collaborator, "King's College London" with 3 trials as a collaborator, "Oxford University Hospitals NHS Trust" with 3 trials as a collaborator and "The Leeds Teaching Hospitals NHS Trust" with 3 trials as a collaborator. Other collaborators include 168 different institutions and companies that were collaborators in the rest 158 trials.

According to Clinical.Site data, the most researched conditions in "Papworth Hospital" are "Cystic Fibrosis" (22 trials), "Coronary Artery Disease" (10 trials), "Idiopathic Pulmonary Fibrosis" (8 trials), "Chronic Thromboembolic Pulmonary Hypertension" (7 trials) and "Atrial Fibrillation" (6 trials). Many other conditions were trialed in "Papworth Hospital" in a lesser frequency.

Most popular intervention types in "Papworth Hospital" are "Drug" (70 trials), "Device" (43 trials), "Procedure" (19 trials), "Other" (10 trials) and "Diagnostic Test" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (26 trials), "IVA" (11 trials), "ELX/TEZ/IVA" (7 trials), "placebo" (6 trials) and "TEZ/IVA" (4 trials). Other intervention names were less common.

The vast majority of trials in "Papworth Hospital" are 153 trials for "All" genders.

Currently, there are NaN active trials in "Papworth Hospital". undefined are not yet recruiting, 30 are recruiting, 10 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 83 completed trials in Papworth Hospital, 3 suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Papworth Hospital, 4 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 35 trials that are defined as “Not Applicable".

Papworth Hospital has several departments that took part in Clinical trials: "Papworth Hospital NHS Foundation Trust; Respiratory Department" - 3 trials